These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

757 related articles for article (PubMed ID: 1706208)

  • 1. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo.
    Rees DD; Palmer RM; Schulz R; Hodson HF; Moncada S
    Br J Pharmacol; 1990 Nov; 101(3):746-52. PubMed ID: 1706208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of nitric oxide synthase inhibitors and dexamethasone with alpha-adrenoceptor-mediated responses in rat aorta.
    Adeagbo AS; Triggle CR
    Br J Pharmacol; 1993 Jun; 109(2):495-501. PubMed ID: 7689395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells.
    McCall TB; Feelisch M; Palmer RM; Moncada S
    Br J Pharmacol; 1991 Jan; 102(1):234-8. PubMed ID: 1710525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of nitric oxide synthesis in the regulation of coronary vascular tone in the isolated perfused rabbit heart.
    Smith RE; Palmer RM; Bucknall CA; Moncada S
    Cardiovasc Res; 1992 May; 26(5):508-12. PubMed ID: 1446321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of basal but not agonist-stimulated activity of nitric oxide in rat aorta by NG-monomethyl-L-arginine.
    Frew JD; Paisley K; Martin W
    Br J Pharmacol; 1993 Nov; 110(3):1003-8. PubMed ID: 7507774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of inhibitors of nitric oxide synthase in immune complex-induced vasculitis.
    Mulligan MS; Moncada S; Ward PA
    Br J Pharmacol; 1992 Dec; 107(4):1159-62. PubMed ID: 1281719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of L-N5-(1-iminoethyl)-ornithine on tone and endothelium-dependent vasodilator responses.
    DeWitt BJ; Champion HC; Marrone JR; McNamara DB; Giles TD; Greenberg SS; Kadowitz PJ
    Am J Physiol; 1997 Sep; 273(3 Pt 1):L588-94. PubMed ID: 9316493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-dependent enhancement or inhibition of endotoxin-induced vascular injury in rat intestine by nitric oxide synthase inhibitors.
    Laszlo F; Whittle BJ; Moncada S
    Br J Pharmacol; 1994 Apr; 111(4):1309-15. PubMed ID: 7518298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro.
    Moore PK; al-Swayeh OA; Chong NW; Evans RA; Gibson A
    Br J Pharmacol; 1990 Feb; 99(2):408-12. PubMed ID: 2328404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the L-arginine:nitric oxide pathway in human platelets.
    Radomski MW; Palmer RM; Moncada S
    Br J Pharmacol; 1990 Oct; 101(2):325-8. PubMed ID: 1701676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of inhibitors of nitric oxide synthase that do not interact with the endothelial cell L-arginine transporter.
    Bogle RG; Moncada S; Pearson JD; Mann GE
    Br J Pharmacol; 1992 Apr; 105(4):768-70. PubMed ID: 1380372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of effects of chronic and acute administration of NG-nitro-L-arginine methyl ester to the rat on inhibition of nitric oxide-mediated responses.
    Bryant CE; Allcock GH; Warner TD
    Br J Pharmacol; 1995 Apr; 114(8):1673-9. PubMed ID: 7541283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction by NG-nitro-L-arginine of H2O2-induced endothelial cell injury.
    Shimizu S; Nomoto M; Yamamoto T; Momose K
    Br J Pharmacol; 1994 Oct; 113(2):564-8. PubMed ID: 7530574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of the vasoconstrictor response to KCL by nitric oxide synthesis inhibition: a comparison with noradrenaline.
    Amerini S; Mantelli L; Ledda F
    Pharmacol Res; 1995; 31(3-4):175-81. PubMed ID: 7543202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of NG-substituted arginines on coronary vascular function after endotoxin.
    Winn MJ; Vallet B; Asante NK; Curtis SE; Cain SM
    J Appl Physiol (1985); 1993 Jul; 75(1):424-31. PubMed ID: 7690746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of brain nitric oxide synthase inhibition in vivo: ex vivo assays of nitric oxide synthase can give incorrect results.
    Salter M; Duffy C; Hazelwood R
    Neuropharmacology; 1995 Mar; 34(3):327-34. PubMed ID: 7543191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mg(2+)-induced endothelium-dependent relaxation of blood vessels and blood pressure lowering: role of NO.
    Yang ZW; Gebrewold A; Nowakowski M; Altura BT; Altura BM
    Am J Physiol Regul Integr Comp Physiol; 2000 Mar; 278(3):R628-39. PubMed ID: 10712282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of NG-substituted analogues of L-arginine on NANC relaxation of the rat anococcygeus and bovine retractor penis muscles and the bovine penile artery.
    Liu XR; Gillespie JS; Gibson IF; Martin W
    Br J Pharmacol; 1991 Sep; 104(1):53-8. PubMed ID: 1786518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of nitric oxide synthase inhibitors on acetylcholine-induced relaxation of rat pulmonary and celiac artery rings.
    Yaghi A; Paterson NA; McCormack DG
    Can J Physiol Pharmacol; 1997 Apr; 75(4):279-86. PubMed ID: 9196853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-arginine and arginine analogues: effects on isolated blood vessels and cultured endothelial cells.
    Schmidt HH; Baeblich SE; Zernikow BC; Klein MM; Böhme E
    Br J Pharmacol; 1990 Sep; 101(1):145-51. PubMed ID: 2282457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.